Skip to main content
. 2011 Dec;23(4):265–270. doi: 10.1007/s11670-011-0265-2

Table 1. Characteristics of 147 patients with stage IB upper lobe NSCLC.

Number(%) Right upper lobe
Left upper lobe
P
Number(%) Number(%)
Age, years 0.30
   <58 51(34.7) 30(39.5) 21(29.6)
   58−68 56(38.1) 29(38.2) 27(38.0)
   >68 40(27.2) 17(22.4) 23(32.4)
Sex 0.09
   Female 64(43.5) 28(36.8) 36(50.7)
   Male 83(56.5) 48(63.2) 35(49.3)
Histological type 0.77
   Adenocarcinoma 96(65.3) 50(65.8) 46(64.8)
   Squamous 37(25.2) 20(26.3) 17(23.9)
   Adenosquamous         14(9.5) 6(7.9) 8(11.3)
Grade of differentiation 0.82
    Well 74(50.3) 41(53.9) 33(46.5)
   Moderate 53(36.1) 26(34.2) 27(38.0)
   Poor         13(8.8) 6(7.9) 7(9.9)
   Unknown 7(4.8) 3(3.9) 4(5.6)
Visceral pleura invasion 0.73
   Present        129(87.8) 66(86.8) 63(88.7)
   Absent 18(12.2) 10(13.2) 8(11.3)
Tumor size, cm 0.09
   ≤3.0 60(40.8) 37(48.7) 23(32.4)
   3.1−5.0 63(42.9) 30(39.5) 33(46.5)
   >5.0 24(16.3) 9(11.8) 15(21.1)
Number of removed LN 0.22
   <7 112(76.2) 52(68.4) 60(84.5)
   ≥7 35(23.8) 24(31.6) 11(15.5)
Number of removed MLN 0.06
   <4 106(72.1) 47(61.8) 59(83.1)
   ≥4 41(27.9) 29(38.2) 12(16.9)
Number of removed SMLNS 0.004
   <2 55(37.4) 20(26.3) 35(49.3)
   ≥2 92(62.6) 56(73.7) 36(50.7)

LN=lymph nodes; MLN=mediastinal lymph nodes; SMLNS=superior mediastinal lymph node stations